Targeted Therapies
Our pipeline emphasizes high value potential first-in-class biologics focused on dysregulated inflammation via the LIGHT-signaling network.
Pipeline
Clinical Stage Pipeline
We are advancing a pipeline that emphasizes high value potential first-in-class biologics focused on dysregulated inflammation via the LIGHT-signaling network.
